The anti-inflammatory effect of kaempferol on early atherosclerosis in high cholesterol fed rabbits

Lipids in Health and Disease

Volumn 12, Issue 1, 2013, Pages

  Kong, Lingxi ^a   Luo, Cheng ^a   Li, Xiuying ^a   Zhou, Yuanda ^a   He, Haixia ^a  

^a THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Atherosclerosis; Inflammation; Kaempferol; Vascular adhesion molecule

Indexed keywords

FENOFIBRATE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; KAEMPFEROL; LIPID; MALONALDEHYDE; MONOCYTE CHEMOTACTIC PROTEIN 1; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; AORTA; ARTICLE; ATHEROSCLEROSIS; BODY WEIGHT; CHOLESTEROL DIET; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVITY; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; LIPID BLOOD LEVEL; MALE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RABBIT; RANDOMIZED CONTROLLED TRIAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAINING;

ANIMALS; AORTA; ATHEROSCLEROSIS; CHEMOKINE CCL2; CHOLESTEROL; DIET, HIGH-FAT; E-SELECTIN; GENE EXPRESSION REGULATION; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-1BETA; KAEMPFEROLS; LIPIDS; MALE; RABBITS; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1;

ORYCTOLAGUS CUNICULUS;

EID: 84880899192     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-12-115     Document Type: Article

References (50)

1. Atherothrombosis: a major health burden. Leys D, Cerebrovasc Dis 2001 11 1 s4
2. Atherosclerosis -an inflammatory disease. Ross R, N Engl J Med 1999 340 115 126 10.1056/NEJM199901143400207 9887164 (Pubitemid 29054847)
3. Atherosclerosis pathophysiology and the role of novel risk factors: a clinicobiochemical perspective. Mallika AV, Goswami B, Rajappa M, Angiology 2007 58 513 522 10.1177/0003319707303443 18024933 (Pubitemid 47622823)
4. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Cybulsky MI, Gimbrone MA, Science 1991 251 788 791 10.1126/science.1990440 1990440
5. Mechanisms that regulate the function of the selectins and their ligands. Vestweber D, Blanks JE, Physiol Rev 1999 79 181 213 9922371 (Pubitemid 29056952)
6. Adhesion molecules and atherogenesis. Huo Y, Ley K, Acta Physiol Scand 2008 171 35 43
7. The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atheroscle-rosis. Davies MJ, Gordon JL, Gearing AJ, Pigott R, Woolf N, Katz D, Kyriakopoulos A, J Pathol 1993 171 223 229 10.1002/path.1711710311 7506307 (Pubitemid 23345967)
8. Patterns of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression in rabbit and mouse atherosclerotic lesions and at sites predisposed to lesion formation. Iiyama K, Hajra L, Iiyama M, Li HM, DiChiara M, Medoff BD, Cybulsky MI, Circ Res 1999 85 199 207 10.1161/01.RES.85.2.199 10417402 (Pubitemid 29343319)
9. Cytokine-regulated expression of E-selectin, intercellular adhesion-1(ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) in human intestinal micro vascular endothelial cells. Haraldsen G, Kvale D, Lien B, Farstad IN, Brandtzaeg P, J Immunol 1996 156 2558 2563 8786319
10. Increased Expression of Interleukin-1 in Coronary Artery Disease With Downregulatory Effects of HMG-CoA Reductase Inhibitors. Wæhre T, Yndestad A, Smith C, Haug T, Tunheim SH, Circulation 2004 109 1966 1972 10.1161/01.CIR.0000125700.33637.B1 15051633 (Pubitemid 38544487)
11. Elevation of tumor necrosis factor-α and increased risk of recurrent coronary events after myocardial infarction. Ridker PM, Rifai N, Pfeffer M, Sacks F, Lepage S, Braunwald E, Circulation 2000 101 2149 2153 10.1161/01.CIR.101.18.2149 10801754 (Pubitemid 30253042)
12. Inflammation and Atherosclerosis. Libby P, Ridker PM, Maseri A, Circulation 2002 105 1135 1143 10.1161/hc0902.104353 11877368 (Pubitemid 34212626)
13. Inflammatory biomarkers in coronary artery disease. Zakynthinos E, Pappa N, J Cardiol 2009 53 317 333 10.1016/j.jjcc.2008.12.007 19477372
14. A Review on the Dietary Flavonoid Kaempferol. Calderón- Montaño JM, Burgos-Morón E, Pérez-Guerrero C, López-Lázaro M, Mini Rev Med Chem 2011 11 298 344 10.2174/138955711795305335 21428901
15. Dietary intakes of flavonols and flavones and coronary heart disease in US women. Lin J, Rexrode KM, Hu F, Albert CM, Chae CU, Rimm EB, Stampfer MJ, Manson JE, Am J Epidemiol 2007 165 1305 1313 10.1093/aje/kwm016 17379619 (Pubitemid 47234326)
16. Flavonoid intake and risk of chronic diseases. Knekt P, Kumpulainen J, Jarvinen R, Rissanen H, Heliovaara M, Reunanen A, Hakulinen T, Aromaa A, Am J Clin Nutr 2002 76 560 568 12198000 (Pubitemid 34920833)
17. Inflammatory reactions in the pathogenesis of atherosclerosis. Fan J, Watanabe T, J Atheroscler Thromb 2003 10 63 71 10.5551/jat.10.63 12740479
18. The laboratory rabbit: an animal model of atherosclerosis research. Yanni AE, Lab Anim 2004 38 246 256 10.1258/002367704323133628 15207035 (Pubitemid 38962073)
19. Role of anti-inflammatory drugs in the treatment of acute coronary syndromes. From athero-inflammation to athero-thrombosis. Altman R, Scazziota A, Rev Esp Cardiol 2003 56 9 15 12549993 (Pubitemid 36267337)
20. Anti-inflammatory agents and antioxidants as a possible "third great wave" in cardiovascular secondary prevention. Bhatt DL, Am J Cardiol 2008 101 4 13
21. Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse. Nakashima Y, Raines EW, Plump AS, Breslow JL, Ross R, Arterioscler Thromb Vasc Biol 1998 18 842 851 10.1161/01.ATV.18.5.842 9598845 (Pubitemid 28267666)
22. Inducible expression of vascular cell adhesion molecule-1 by vascular smooth muscle cells in vitro and within rabbit atheroma. Li H, Cybulsky MI, Gimbrone MA, Libby P, Am J Pathol 1993 143 1551 1559 7504883 (Pubitemid 24058258)
23. Leukocyte-Endothelium Interaction During the Early Stages of Hypercholesterolemia in the Rabbit Role of P-Selectin, ICAM-1, and VCAM-1. Scalia R, Appel JZ, Lefer AM, Arterioscler Thromb Vasc Biol 1998 18 1093 1100 10.1161/01.ATV.18.7.1093 9672069 (Pubitemid 28323593)
24. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases. The atherosclerosis risk in communities (ARIC) study. Hwang SJ, Ballantyne CM, Sharrett AR, Smith LC, Davis LE, Circulation 1997 96 4219 4225 10.1161/01.CIR.96.12.4219 9416885 (Pubitemid 28007447)
25. The Role of MCP-1 in Atherosclerosis. Harrington JR, Stem Cells 2000 18 65 66 10.1634/stemcells.18-1-65 10661575 (Pubitemid 30064895)
26. Expression of monocyte chemoat-tractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Yla-Herttuala S, Lipton BA, Rosenfeld ME, Sarkioja T, Yoshimura T, Leonard EJ, Witztum JL, Steinberg D, Proc Natl Acad Sci USA 1991 88 5252 5256 10.1073/pnas.88.12.5252 2052604 (Pubitemid 21914722)
27. Elevated monocyte chemoattractant protein-1 serum levels in patients at risk for coronary artery disease. Martinovic I, Abegunewardene N, Seul M, Vosseler M, Horstick G, Buerke M, Darius H, Lindemann S, Circ J 2005 69 1484 1489 10.1253/circj.69.1484 16308496 (Pubitemid 41743963)
28. Effects of IL-1beta, TNF-alpha and lipopolysaccharide on the expression of MCP-1 in human umbilical vein endothelial cells. Meng F, Deng Z, Zhonghua Bing li xue za zhi Chinese Journal of Pathology 2000 29 46 48 11866893
29. Curcumin inhibits ox-LDL-induced MCP-1 expression by suppressing the p38MAPK and NF-κB pathways in rat vascular smooth muscle cells. Zhong Y, Liu TR, Guo ZG, Inflamm Res 2012 61 61 67 10.1007/s00011-011-0389-3 22005927
30. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in Low density lipoprotein receptor-deficient mice. Gu L, Okada Y, Clinton SK, Gerard G, Sukhova GK, Libby P, Rollins BJ, Mol Cell 1998 2 275 281 10.1016/S1097-2765(00)80139-2 9734366 (Pubitemid 128373654)
31. The flavonoid phloretin suppresses stimulated expression of endothelial adhesion molecules and reduces activation of human platelets. Stangl V, Lorenz M, Ludwig A, Grimbo N, Guether C, Sanad W, J Nutr 2005 135 172 178 15671209 (Pubitemid 40194474)
32. Dietary flavonoid apigenin inhibits high glucose and tumor necrosis factor alpha-induced adhesion molecule expression in human endothelial cells. Yamagata K, Miyashita A, Matsufuji H, Chino M, J Nutr Biochem 2010 21 116 124 10.1016/j.jnutbio.2008.11.003 19195861
33. Inhibitory effects of several flavonoids on E-selectin expression on human umbilical vein endothelial cells stimulated by tumor necrosis factor-α Takano-Ishikawa Y, Goto M, Yamaki K, Phytother Res 2003 17 1224 1227 10.1002/ptr.1371 14669262 (Pubitemid 38057185)
34. Biofalvonoid quercetin inhibits interleukin-1-induced transcriptional expression of monocyte chemoattractant protein-1 in glomerular cells via suppression of nuclear factor-kappaB. Ishikawa Y, Sugiyama H, Stylianou E, Kitamura M, J Am Soc Nephrol 1999 10 2290 2296 10541287 (Pubitemid 29501461)
35. Nuclear Factor κB Signaling in Atherogenesis. De Winther MJP, Kanters E, Kraal G, Hofker MH, Arterioscler Thromb Vasc Biol 2005 25 904 914 10.1161/01.ATV.0000160340.72641.87 15731497 (Pubitemid 40627833)
36. Transcriptional regulation of endothelial cell adhesion molecules: NF- kappa B and cytokine- inducible enhancers. Collins T, Read MA, Neish AS, Whitley MZ, Thanos D, Maniatis T, FASEB J 1995 9 899 909 7542214
37. Temporal and spatial distribution of interleukin-1 beta in balloon injured porcine coronary arteries. Chamberlain J, Gunn J, Francis S, Holt C, Crossman D, Cardiovasc Res 1999 44 156 165 10.1016/S0008-6363(99)00175-3 10615399 (Pubitemid 29431693)
38. Proliferating arterial smooth muscle cells after balloon injury express TNF-alpha but not interleukin-1 or basic fibroblast growth factor. Tanaka H, Sukhova G, Schwartz D, Libby P, Arterioscler Thromb Vasc Biol 1996 16 12 18 10.1161/01.ATV.16.1.12 8548411 (Pubitemid 26026926)
39. In vivo blockade of tumor necrosis factor accelerates functional endothelial recovery after balloon angioplasty. Krasinski K, Spyridopoulos I, Kearney M, Losordo DW, Circulation 2001 104 1754 1756 10.1161/hc4001.098046 11591609 (Pubitemid 32963337)
40. Disruption of tumor necrosis factor-α gene diminishes the development of atherosclerosis in ApoE-deficient mice. Ohta H, Wada H, Niwa T, Kirii H, Iwamoto N, Saitoa K, Sekikawab K, Seishima M, Atherosclerosis 2005 180 11 17 10.1016/j.atherosclerosis.2004.11.016 15823270
41. Monoclonal antibodies targeting IL-1 beta reduce biomarkers of atherosclerosis in vitro and inhibit atherosclerotic plaque formation in Apolipoprotein E-deficient mice. Bhaskar V, Yin J, Mirza AM, Phan D, Vanegas S, Issafras H, Michelson K, Hunter JJ, Kantak SS, Atherosclerosis 2011 216 313 320 10.1016/j.atherosclerosis.2011.02.026 21411094
42. Inhibitory effects of flavonoids on TNF-alpha-induced IL-8 gene expression in HEK 293 cells. Lee S, Kim YJ, Kwon S, Lee Y, Choi SY, Park J, Kwon HJ, BMB Rep 2009 42 265 270 10.5483/BMBRep.2009.42.5.265 19470239
43. Effect of apigenin, kaempferol and resveratrol on the expression of interleukin-1beta and tumor necrosis factor-alpha genes in J774.2 macrophages. Kowalski J, Samojedny A, Paul M, Pietsz G, Wilczok T, Pharmacol Re 2005 57 390 394 (Pubitemid 41030701)
44. Antioxidants and atherosclerotic heart disease. Diaz MN, Frei B, Vita JA, Keaney JF, New Engl J Med 1997 337 408 416 10.1056/NEJM199708073370607 9241131 (Pubitemid 27328371)
45. Free radicals and antioxidants in cardiovascular health and disease. Bahorun T, Soobrattee MA, Luximon-Ramma A, Aruoma OI, Internet Journal of Medical Update 2006 1 25 41
46. Distinctive antioxidant and antiinflammatory effects of flavonols. Wang L, Tu YC, Lian TW, Hung JT, Yen JH, Wu MJ, J Agric Food Chem 2006 54 9798 9804 10.1021/jf0620719 17177504 (Pubitemid 46158973)
47. Measurement of xanthine oxidase inhibition activity of phenolics and flavonoids with a modified cupric reducing antioxidant capacity (CUPRAC) method. Ozyurek M, Bektasoglu B, Guclu K, Apak R, Anal Chim Acta 2009 636 42 50 10.1016/j.aca.2009.01.037 19231354
48. In-vivo and in-vitro assessment of the free-radical-scavenger activity of Ginkgo flavone glycosides at high concentration. Hibatallah J, Carduner C, Poelman MC, J Pharm Pharmacol 1999 51 1435 1440 10.1211/0022357991777083 10678500 (Pubitemid 30064075)
49. In vitro and in vivo antioxidant properties of different fractions of Moringa oleifera leaves. Verma AR, Vijayakumar M, Mathela CS, Rao CV, Food Chem Toxicol 2009 47 2196 2201 10.1016/j.fct.2009.06.005 19520138
50. Role of oxidative modifications in atherosclerosis. Stocker R, Keaney JF, Physiol Rev 2004 84 1381 1478 10.1152/physrev.00047.2003 15383655 (Pubitemid 39302636)